Next-generation Alzheimer’s drug cuts risk of serious brain bleeds

A new Alzheimer's drug has been shown to significantly reduce the risk of serious brain bleeds, a common side effect of existing treatments. The development could lead to safer therapies for patients with the disease, potentially changing how Alzheimer's is managed. This advance addresses a key safety concern in the field.

Sources (2)